Fifth Third Bancorp’s iRadimed IRMD Stock Holding History

Fifth Third Bancorp’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$198K	Buy	+2,052	New	+$205K	﹤0.01%	2552
2023 Q4	–	Sell	-283	Closed	-$12.6K	–	2581
2023 Q3	$12.6K	Hold	283	–	–	﹤0.01%	1889
2023 Q2	$13.5K	Hold	283	–	–	﹤0.01%	1885
2023 Q1	$11.1K	Hold	283	–	–	﹤0.01%	2055
2022 Q4	$8.01K	Hold	283	–	–	﹤0.01%	2045
2022 Q3	$9K	Hold	283	–	–	﹤0.01%	1987
2022 Q2	$10K	Hold	283	–	–	﹤0.01%	1996
2022 Q1	$13K	Hold	283	–	–	﹤0.01%	1957
2021 Q4	$13K	Hold	283	–	–	﹤0.01%	2000
2021 Q3	$10K	Buy	+283	New	+$9.62K	﹤0.01%	2005

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's IRMD Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in iRadimed (IRMD) in Q1 2026: 2,052 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #2552 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in IRMD as recently as Q3 2023.

Fifth Third Bancorp first reported a position in IRMD in Q3 2021 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Fifth Third Bancorp held 2,052 shares of iRadimed worth $198K as of Q1 2026.
iRadimed was a new Fifth Third Bancorp position in Q1 2026.
iRadimed made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2552 holding.
Fifth Third Bancorp first reported a position in iRadimed in Q3 2021 and has held it in 10 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.